The responses are from January 2013 and feature DARA BioSciences $DARA, Dynavax Technologies $DVAX, FluoroPharma Medical $FPMI, pSivida Corp $PSDV, and Senesco Technologies $SNTI.
Check out the complete index of all IR Questions and Answers.
Note that the DVAX page also includes the slide deck from their recent presentation at the 2013 JP Morgan Healthcare conference. They have an upcoming PDUFA date for Heplisav, a product for Hepatitis B Virus infection.